Final Line-Up Announced for JTC Team’s Virtual Investor Pitch Conference

Frenchtown, NJ / ACCESSWIRE / June 17, 2024 / JTC Team, a corporate communications and investor relations firm, has announced the final line-up of companies for its two-day Virtual Investor Pitch Conference starting today.

Participating companies will present their "elevator pitches" and upcoming milestones. Investors can submit questions live during the event, which companies will answer within the allotted time. The full event schedule is available at www.virtualinvestorco.com.

Monday’s schedule includes Kaida BioPharma, Adolore BioTherapeutics, Palisade Bio, AIM ImmunoTech, and enVVeno Medical Corporation. Tuesday features Royalty Management Holding, GRI Bio, Outlook Therapeutics, American Resources Corporation, Annovis Bio, and Moleculin Biotech.

Webcast replays will be available for 90 days after the event concludes. For access, visit www.virtualinvestorco.com.